論文

査読有り 国際誌
2022年6月8日

Development of healthy lifestyle consciousness index for gynecological cancer patients.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
  • Nozomi Higashiyama
  • ,
  • Ken Yamaguchi
  • ,
  • Yosuke Yamamoto
  • ,
  • Akihiko Ueda
  • ,
  • Yoshihide Inayama
  • ,
  • Miho Egawa
  • ,
  • Koji Yamanoi
  • ,
  • Mana Taki
  • ,
  • Masayo Ukita
  • ,
  • Yuko Hosoe
  • ,
  • Akihito Horie
  • ,
  • Junzo Hamanishi
  • ,
  • Masaki Mandai

30
9
開始ページ
7569
終了ページ
7574
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1007/s00520-022-07179-z

PURPOSE: Healthy lifestyle is related to quality of life (QOL) after cancer diagnosis and prognosis. However, there are few reports on patients conscious of healthy lifestyle and patients requiring medical providers' attention regarding healthy lifestyle. We aimed to develop a healthy lifestyle consciousness index (HLCI) for cancer patients and evaluated its validity in gynecological cancer patients. METHODS: The HLCI was designed to assess degree of healthy lifestyle consciousness, including items regarding "diet," "exercise," "body weight," and "sleep." Exploratory factor analysis was performed for dimensionality of the scale; Cronbach's alpha was calculated to assess internal-consistency reliability. For criterion-based validity, we calculated proportions of stage III/IV gynecological malignancies in those with categorized HLCI scores based on tertiles. Concurrent validity was evaluated between HLCI and other quality of life (QOL) scales including European Organization for Research and Treatment of Cancer QLQ-C30 in limited patients. RESULTS: HLCI comprised five 10-point items (0-45); higher values implied improved healthy lifestyle consciousness. Data from 108 gynecological malignancy patients at Kyoto University Hospital were analyzed. The mean age of subjects was 55.8 years; 36.1% of them had uterine corpus cancer; 34.3% were at stage III/IV of gynecological malignancy. The factor analysis revealed HLCI was unidimensional; the reliability based on Cronbach's alpha was satisfactory (0.88). The proportions of stage III/IV gynecological malignancies were 25.7%, 33.3%, and 44.4% in those with first (7-24 points), second (25-30 points), and third (31-46 points) tertiles of HLCI score, respectively. For patients with other QOL scales (n = 25), the mean scores of global health status of QLQ-C30 were 33.3, 50.0, and 83.3 for first, second, and third tertiles of HLCI score, respectively. CONCLUSION: HLCI was successfully validated; thus, patients with advanced stages or higher QOL might have strong consciousness regarding healthy lifestyle. HLCI may be useful in precision care for improved lifestyles and QOL.

リンク情報
DOI
https://doi.org/10.1007/s00520-022-07179-z
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/35674795
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385809
ID情報
  • DOI : 10.1007/s00520-022-07179-z
  • PubMed ID : 35674795
  • PubMed Central 記事ID : PMC9385809

エクスポート
BibTeX RIS